Pain is a widespread health challenge. Global estimates suggest that 10–30% of adults live with persistent pain. In the United States, nearly 25% of adults report chronic pain, making it a leading cause of disability.
The impact of pain extends beyond physical discomfort. It is closely linked to depression, anxiety, sleep disruption, reduced mobility, social withdrawal, economic cost, and loss of productivity.
Conventional pain treatments are beneficial but have their limitations. Opioids have risks of dependence and overdose, while NSAIDs are associated with gastrointestinal and kidney complications when used for a long time. A significant number of patients either learn to live with the pain or find relief at very high trade-offs.
As pain management continues to demand alternative therapeutic approaches, cannabis has emerged as a subject of considerable scientific interest for its potential analgesic effect. This comprehensive guide examines the current evidence regarding cannabis as a pain-relieving agent, exploring its mechanisms of action, and considerations for therapeutic use.
Understanding Cannabis
Cannabis is not a single substance. It contains over 100 distinct phytocannabinoids, with delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) representing the most extensively studied compounds. These compounds interact with the body's endocannabinoid system, which is a complex network that plays a role in regulating various processes, like pain perception, inflammation, and immune response.
The endocannabinoid system comprises receptors (CB1 and CB2), cannabinoids produced by the body, and enzymes responsible for their production and breakdown. CB1 receptors are predominantly located in the central nervous system, while CB2 receptors are found primarily in peripheral tissues and immune cells.
Mechanisms of Pain Relief
Cannabis appears to modulate pain through several distinct mechanisms. THC demonstrates direct agonist activity at CB1 receptors while CBD, exhibits a more complex pharmacological activity.
Then, there is the entourage effect, which brings all other minor cannabinoids into play. The entourage effect is a proposed complementary interaction between minor cannabis compounds like cannabinoids, terpenes, and flavonoids. It has garnered scientific attention as a potential mechanism for enhanced therapeutic efficacy.
Clinical Evidence for Pain Management
Chronic Pain
Chronic pain represents one of the most frequently cited indications for medical cannabis use in the United States. A comprehensive report by the National Academies of Sciences concluded that there is substantial evidence that cannabis is an effective treatment for chronic pain in adults.
Neuropathic Pain
Neuropathic pain is chronic pain that results from damage to the nervous system. A systematic review published in 2025 noted that cannabis has shown promise in the management of chronic neuropathic pain while noting the need for more research.
Considerations for Therapeutic Use
Safety Note: Pregnant and breastfeeding individuals should avoid cannabis use due to potential developmental risks. The ACOG strongly recommends against cannabis use during pregnancy and lactation.
Elderly Patients
Older adults represent a growing demographic of medical cannabis users. While medical cannabis may be safe and effective when properly monitored, this population may be more susceptible to adverse effects, including cognitive impairment and falls.
Patient Education
- The difference between medical and recreational cannabis use
- Proper administration techniques and dosing principles
- Recognition of adverse effects and when to seek medical attention
- The importance of avoiding driving or operating machinery while impaired
- Risks of combining cannabis with alcohol or other sedating substances
Conclusion
Cannabis demonstrates promising potential as an adjunctive therapy for various pain conditions, supported by an expanding body of clinical evidence. For U.S. patients suffering from various forms of chronic pain, medical cannabis is an option worthy of consideration.
Healthcare providers and patients must engage in thoughtful, evidence-based discussions regarding the potential benefits and risks of cannabis therapy within the context of each individual's circumstances.